GSK3B and ductal breast carcinoma in situ: In this study we report the contribution and prognostic significance of GSK3B to two breast cancer subtypes;ductal carcinoma in-situ (DCIS) and invasive ductal carcinoma (IDC) using the Oncomine platform.